TrialStem cell research & therapy2026

Safety and preliminary efficacy of autologous bone marrow-derived mesenchymal stem cell transplantation in hereditary cerebellar ataxia: phase I/IIa clinical trial.

Abbas Shapouri Moghaddam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.